-- 根據FactSet調查的分析師報告，百健（Biogen，股票代碼：BIIB）的平均評級為“增持”，平均目標價為213.07美元。 （報道北美、亞洲和歐洲主要銀行及研究機構的股票、商品和經濟研究。研究機構可透過以下連結聯絡我們：https://www..com/contact-us）
Related Articles
Asia
Correction: Ningbo Joyson Electronic's Q1 Profit Climbs 18%
(Corrects period in first paragraph to first quarter of 2026)Ningbo Joyson Electronic (HKG:0699, SHA:600699) recorded an 18% rise in attributable profit in the first quarter of 2026 to 402.1 million yuan from 340.5 million yuan a year prior, according to a Monday Hong Kong bourse filing.Earnings per share increased to 0.26 yuan from 0.24 yuan in the corresponding period of the previous fiscal year.Operating income slipped 5.2% to 13.8 billion yuan from 14.6 billion yuan in the year-ago period.
$HKG:0699$SHA:600699
Mining & Metals
Greenland Resources Providing Update on EUR 50 Equity Investment Led by Horizon Eur
$MOLY.TO
Asia
Ningbo Joyson Electronic's Q1 Profit Climbs 18%
Ningbo Joyson Electronic (HKG:0699, SHA:600699) recorded an 18% rise in attributable profit in the first quarter of 2025 to 402.1 million yuan from 340.5 million yuan a year prior, according to a Monday Hong Kong bourse filing.Earnings per share increased to 0.26 yuan from 0.24 yuan in the corresponding period of the previous fiscal year.Operating income slipped 5.2% to 13.8 billion yuan from 14.6 billion yuan in the year-ago period.
$HKG:0699$SHA:600699